ClinicalTrials.gg
RecruitingNCT07476560MeMaUpdated Mar 17, 2026

Evaluating the Efficacy of Suture Mesh vs. Planar Mesh in Ventral Hernia Treatment

An interventional study of mesh suture and planar mesh in Abdominal Wall Hernia, Umbilical Hernia Repair and Epigastric Hernia Repair, sponsored by Regionshospital Nordjylland. Recruiting at 1 site in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-17.

Sponsored by Regionshospital Nordjylland · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Jan 2026; still recruiting 10 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
280
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this clinical trial is to investigate whether mesh-suture affects wound complication rates, patient-reported quality of life, and operation time in adult patients undergoing surgery for small ventral hernias.

The main questions it aims to answer are:

Does mesh-suture reduce wound complication rates compared to planar mesh? Does mesh-suture improve patient-reported quality of life(QoL) and affect operation time compared to planar mesh?

Comparison group:

Researchers will compare standard treatment with planar mesh to the interventional treatment with mesh-suture to see whether mesh-suture leads to fewer complications, better quality of life, and shorter operation time.

Participants will:

Be randomized to receive either planar mesh or mesh-suture during hernia repair surgery.

Undergo standardized preoperative assessment, including baseline data and QoL scoring.

Attend a postoperative visit on day 7-13 for wound inspection and ultrasound. Complete QoL assessments at 90 days (telephone follow-up). Have operation time recorded and medical records reviewed for readmissions within 90 days.

02

Conditions studied

  • Abdominal Wall Hernia
  • Umbilical Hernia Repair
  • Epigastric Hernia Repair

Browse trials for

03

In context

Hernia, Abdominal

82 studies on the registry are indexed under Hernia, Abdominal; 19 are open to participants now.

This study's planned enrollment of 280 is above the median of 90 across 48 interventional studies indexed under Hernia, Abdominal.

Browse Hernia, Abdominal studies →

Lead sponsor

Regionshospital Nordjylland is the lead sponsor of 18 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Ventral hernia (maximum size 3 × 3 cm) measured with Ultrasound or CT.
  • Participants must be eligible for surgical repair using either mesh-suture or planar mesh

Exclusion criteria

Exclusion Criteria:

  • Age \< 18 years.
  • Acute (emergent) operation.
  • Pregnancy.
  • Women with plans for future pregnancies.
  • Withdrawal of during admission.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
280 participants (estimated)

Study arms

  • Experimental
    mesh suture

    Device: mesh suture

  • Active comparator
    planar mesh

    Device: planar mesh

Interventions

  • Devicemesh suture

    mesh suture

  • Deviceplanar mesh

    planar mesh

06

What researchers measure

Primary outcomes

  1. Surgical Site Occurrences (SSO) Assessed by Clinical Examination and Ultrasound

    Definition: We will apply the standardized CDC (Centers for Disease Control and Prevention ) and VHWG (Ventral Hernia Working Group) definitions for SSO. Evaluation: Clinical examination. Additionally, an ultrasound examination will be performed.

    Time frame: 7-13 days after operation

Secondary outcomes

  1. Abdominal Hernia-Q Questionnaire

    Scale description: Disease-specific patient-reported outcome measure for abdominal hernia symptoms and quality of life. Score range: Each domain ranges from 1 to 4, where higher scores indicate better health status and fewer symptoms.

    Time frame: preoperative, postoperative day 10, day 90

  2. EQ-5D-5L Index Score

    Scale description: Generic health-related quality-of-life instrument assessing five dimensions of health. Score range: The Index Score ranges from \< 0 (worst health state, depending on country value set) to 1 (perfect health) and

    Time frame: preoperative, postoperative day 10, day 90

  3. EQ-VAS (Visual Analogue Scale)

    Patients rate their overall health on a vertical scale from 0 to 100. Interpretation: Higher scores indicate better overall health-related quality of life.

    Time frame: preoperative, postoperative day 10, day 90

  4. DURATION OF SURGERY

    Operation time measured in minutes

    Time frame: The time interval from the first incision to the last stitch is set

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Gameza V, Brandenburger N, Leutscher P, Holte K. Protocol for the mesh matters project: evaluating the efficacy of suture mesh vs. planar mesh in small ventral hernia repair - a randomized, blinded multicenter study. Hernia. 2026 Jul 31;30(1):310. doi: 10.1007/s10029-026-03815-3. PubMed 42536214 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No — Ethics commettee requirements

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07476560
Lead sponsor
Regionshospital Nordjylland
Responsible party
Sponsor
First posted
Mar 17, 2026
Start date
Jan 5, 2026
Primary completion
Dec 31, 2027 (estimated)
Completion
Dec 31, 2032 (estimated)
Last update
Mar 17, 2026

Study contacts

Vitaly A Gameza
Contact
vitgam@rn.dk
045 97640520
Katrine Holte
Contact
k.holte@rn.dk
045 97640520
Nils Brandenburger
study chair · Regionhospital Nordjylland

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion